Neural stem cells (NSCs) derived from human induced pluripotent stem cells were used to investigate effects of exposure to the food contaminant acrylamide (AA) and its main metabolite glycidamide (GA) on key neurodevelopmental processes. Diet is an important source of human AA exposure for pregnant women, and AA is known to pass the placenta and the new born may also be exposed through breast feeding after birth. The NSCs were exposed to AA and GA (1x10-8 – 3x10-3 M) under 7 days of proliferation and up to 28 days of differentiation towards a mixed culture of neurons and astrocytes. Effects on cell viability was measured using Alamar Blue™ cell viability assay, alterations in gene expression were assessed using real time PCR and RNA sequencing, and protein levels were quantified using immunocytochemistry and high content imaging. Effects of AA and GA on neurodevelopmental processes were evaluated using endpoints linked to common key events identified in the existing developmental neurotoxicity adverse outcome pathways (AOPs). Our results suggest that AA and GA at low concentrations (1x10-7 - 1x10-8 M) increased cell viability and markers of proliferation both in proliferating NSCs (7 days) and in maturing neurons after 14 to 28 days of differentiation.
LAUVÅS Anna Jacobsen;
LISLIEN Malene;
HOLME Jorn;
DIRVEN Hubert;
PAULSEN Ragnhild E;
ALM Inger Margit;
ANDERSEN Jill Mari;
SKARPEN Ellen;
SORENSEN Vigdis;
MACKO Peter;
PISTOLLATO Francesca;
DUALE Nur;
MYHRE Oddvar;
Lauvås, A.J., Lislien, M., Holme, J., Dirven, H., Paulsen, R.E., Alm, I.M., Andersen, J.M., Skarpen, E., Sorensen, V., Macko, P., Pistollato, F., Duale, N. and Myhre, O., Developmental neurotoxicity of acrylamide and its metabolite glycidamide in a human mixed culture of neurons and astrocytes undergoing differentiation in concentrations relevant for human exposure, NEUROTOXICOLOGY, ISSN 0161-813X, 92, 2022, p. 33-48, JRC130093.
2022-09-14
ELSEVIER
JRC130093
0161-813X (online),
https://www.sciencedirect.com/science/article/pii/S0161813X22001164,
https://publications.jrc.ec.europa.eu/repository/handle/JRC130093,
10.1016/j.neuro.2022.07.001 (online),
